Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Craig W. Hendrix, M.D.
Craig Walter Hendrix, M.D.
Wellcome Professor and Director, Division of Clinical Pharmacology
Professor of Medicine
Research Interests: Chemoprevention of HIV infection; Drug interactions; Clinical pharmacology of antiviral drugs; Topical HIV microbicides
Contact for Research Inquiries
600 N. Wolfe Street
Baltimore, MD 21287 map
Dr. Hendrix is a Professor of Medicine and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine. He has 28 years of experience in the design and conduct of translational clinical pharmacology studies, mostly of antiretroviral drugs for HIV treatment and prevention. He is the Wellcome Professor and Director, Division of Clinical Pharmacology and Director of the Drug Development Unit in the Division. His research focuses on development of antiretroviral drugs to prevent HIV infection. His HIV prevention research has been supported by CDC, NIH, USAID, the Bill and Melinda Gates Foundation, amfAR, and sponsors in the pharmaceutical industry.
Dr. Hendrix received his undergraduate degree in Applied Biology at MIT (1978) and his medical degree from Georgetown University, magna cum laude (1984). He completed internship and residency in internal medicine on the Osler Medical Service, and fellowships in Infectious Diseases and Clinical Pharmacology at The Johns Hopkins Hospital. Before joining the Hopkins medical school faculty, Dr. Hendrix served on active duty for 10 years in the U.S. Air Force (USAF).
Dr. Hendrix was appointed as the Wellcome Professor and Director, Division of Clinical Pharmacology in January 2015. Established in 1954, the Division of Clinical Pharmacology at The Johns Hopkins University School of Medicine is the oldest in the US and has a long history of laboratory and clinical research, teaching, and service activities.
Mentoring and teaching medical students, graduate students, and post-doctoral fellows have long been his passion and integral to the success of his own research accomplishments.
- Wellcome Professor and Director, Division of Clinical Pharmacology
- Director, Drug Development Unit
- Deputy Director, Translational Science Core, Institute for Clinical and Translational Research (CTSA)
- Professor of Medicine
- Professor of Pharmacology and Molecular Sciences
- American Board of Internal Medicine (1987)
- American Board if Internal Medicine - Infectious Diseases (1990)
The Johns Hopkins Hospital Osler Medical Service, Baltimore, MD, 1987, Internal Medicine Residency; Johns Hopkins University School of Medicine, Baltimore, MD, 1989, Infectious Diseases, Clinical Pharmacology
Research & Publications
Dr. Hendrix's primary research focus is chemoprevention of HIV infection. This involves oral, topical, and injectible HIV microbicide development. He conducts small, intensive sampling studies of PK and PD of drugs for HIV prevention with a focus on developing methods to better understand HIV and drug distribution in the male genital tract, female genital tract and lower gastrointestinal tract. He also supports numerous HIV pre-exposure prophylaxis development studies from phase I to phase III, largely as leader of the Pharmacology Core Laboratory of both the Microbicide Trial Network and HIV PRevnetion Trials Network.
Lab Website: Clinical Laboratory and Biomarkers Core
Academic Affiliations & Courses
Graduate Program Affiliation
Clinical Pharmacology Training Program
Graduate Training Program in Clinical Investigation
Research Training in Microbial Diseases
Activities & Honors
- PhRMA Foundation Award in Excellence, 2017
- David M. Levine Faculty Mentoring Award, Department of Medicine
- Excellence in Teaching Award, Johns Hopkins Alumni Association
- American Society of Clinical Pharmacology and Therapeutics
- American Society for Clinical Pharmacology and Therapeutics